Nasohist Pediatric

Nasohist Pediatric

Nasohist Pediatric Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

Do not exceed recommended dosage.

  • in a child who is taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug.  If you do not know if your child's prescription drug contains an MAOI, ask a doctor or pharmacist before giving this product
  • a breathing problem such as chronic bronchitis
  • glaucoma
  • heart disease
  • high blood pressure
  • thyroid disease
  • diabetes mellitus
is taking sedatives or tranquilizers.
  • nervousness, dizziness, or sleeplessness occur
  • symptoms do not improve within 7 days or are accompanied by a fever
  • new symptoms occur

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:

  • runny nose
  • sneezing
  • itching of the nose or throat
  • itchy, watery eyes
  • nasal congestion
  • reduces swelling of nasal passages

History

There is currently no drug history available for this drug.

Other Information

There are no additional details available for this product.

Nasohist Pediatric Manufacturers


  • Hawthorn Pharmaceuticals, Inc.
    Nasohist Pediatric (Chlorpheniramine Maleate, Phenylephrine Hydrochloride) Liquid [Hawthorn Pharmaceuticals, Inc.]

Login To Your Free Account